Business & Finance
Coley Pharmaceutical Group reports Q4 revenue of $5.4 million
Published in Clinical Trials Week, March 20th, 2006
Coley Pharmaceutical Group, Inc., (COLY), a biopharmaceutical company discovering and developing a class of drug candidates known as TLR Therapeutics, reported its financial results for the quarter and year ended December 31, 2005. Fourth-quarter revenues were $5.4 million; Coley reported a net loss attributable to common shareholders in the fourth quarter of 2005 of $7.0 million versus $9.5 million in the same period of 2004.
Total revenues were $5.4 million in the fourth quarter of 2005 compared to $3.0 million in 2004. Revenue increased in 2005 primarily as a result of revenue recognized under Coley's 2005 licensing agreement with Pfizer, Inc.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
Source: Clinical Trials Week (2006-03-20)
More Articles from Clinical Trials Week
- Biliary Tract Carcinoma
Biliary tract carcinoma treated by chemoradiation - Cystic Fibrosis
Inhaled hypertonic saline is safe and effective additional therapy for cystic fibrosis patients - Emergency Medicine
Electronic link between emergency and family physicians does not lower resource use - Mental Health
Treatment-resistant depression responds to sequential bilateral rTMS - Adenomas
DNA methylation patterns of adenomas studied - Aggressive Behavior
Characterization of aggressive behavior influences the success of pharmacological treatment - More from this issue of Clinical Trials Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
